Catheter-based renal denervation with the Symplicity Spyral system safely reduced blood pressure and medication burden in patients with resistant hypertension.
Does catheter-based renal denervation using the Symplicity Spyral system reduce blood pressure and medication burden in patients with resistant hypertension?
Catheter-based renal denervation with the Symplicity Spyral system appears safe and effective for reducing blood pressure and medication burden in patients with resistant hypertension.
Absolute Event Rate: 0% vs 0%
Catheter-based RDN using the Symplicity Spyral system was safe and effective in reducing BP and medication burden in patients with resistant HT. These results support RDN as a potential therapeutic option in appropriately selected patients.
Zehir et al. (Thu,) reported a other. Catheter-based renal denervation with the Symplicity Spyral system safely reduced blood pressure and medication burden in patients with resistant hypertension.